An established New Jersey-based executive in the biopharmaceutical sphere, Loretta Itri, MD, has facilitated the development of multiple cancer drugs. An avid theatergoer, Dr. Loretta Itri recently took in a unique Broadway production of King Lear starring English actress Glenda Jackson. Having earned two Oscars across a storied acting career, Ms. Jackson held an elected seat in Parliament before being enticed back into acting on the London stage in 2016 at age 80. Despite an absence of two decades from thespian activities, she earned plaudits for her take on Shakespeare’s tragic king in an Old Vic performance directed by Deborah Warner. Instead of crossing the Atlantic with the production as expected, Ms. Jackson next earned a Tony Award for Best Actress in a Play for her portrayal of an “angry old woman” in Three Tall Women by Edward Albee. The King Lear production currently running on Broadway has a new supporting cast and features the often-subversive vision of director Sam Gold, who previously cast Daniel Craig in Othello.
0 Comments
An experienced pharmaceutical professional, Loretta Itri serves as the Executive Vice President of Global Health Sciences and Regulatory Affairs at The Medicines Company. A fan of musicals, Loretta Itri has enjoyed attending Broadway productions such as Bright Star. Since holding its world premiere at the Old Globe Theatre in San Diego, Bright Star has taken Broadway by storm. Set in mid-1940s North Carolina, the show follows the lives and affairs of Asheville Southern Journal editor Alice Murphy and World War II veteran Billy Cane. Tony-winning director Walter Bobbie brings these stories to life amidst a soundtrack of bluegrass-inspired music. The group of media and writing professionals from the New York Outer Critics Circle recently celebrated the 2015-16 Broadway season during its annual awards. Among a list of nominees that included Waitress, Tuck Everlasting, and American Psycho, Bright Star won the title of Best New Broadway Musical. The show also earned recognition for its score, triumphing in the Outstanding New Score category for Broadway or off-Broadway productions. In addition to its wins, Bright Star was nominated in several other categories, including Outstanding Director and Outstanding Choreographer. Executive vice president of global health sciences and regulatory affairs at the Medicines Company, Loretta Itri handles worldwide and clinical development oversight. In her free time, Loretta Itri is an avid theater-goer and subscribes to such New York-based companies as the Roundabout Theatre Company. As a part of its mission to share stories from some of the finest theatre artists, the Roundabout Theatre Company maintains its New Play Initiative, a project that seeks to bring about new works and highlight gifted playwrights. The Initiative stemmed from the company’s development into a leading Broadway producer of contemporary and classic revivals in 1995. As Roundabout grew in size and popularity, so did its commitment to producing new plays and, eventually, the New Play Initiative was established. Taking a three-step approach to bringing new plays into the spotlight, the New Play Initiative commissions new works, conducts workshops and readings, and produces those new works as mainstage productions and through the Roundabout Underground program. Over the past two decades, the Initiative has produced dozens of new works, along with workshops for more than 170 works, and 36 playwright commissions. |
AuthorAs chief medical officer and president of pharmaceutical development at a public biotech company, Dr. Loretta Itri oversaw the worldwide development of a number of important drugs, including Tesetaxel, a novel oral taxane used in the treatment of breast, gastric, and prostate cancer. Archives
October 2019
Categories |